Oxford-AstraZeneca vaccine trials would be over by January ; Adar Poonawala


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Oxford-AstraZeneca vaccine trials would be over by January ; Adar Poonawala

Oxford and AstraZeneca’s Covid-19 vaccine trials in India are expected to be over by January, said Serum Institute of India (SII) CEO Adar Poonawalla. Speaking to India Today TV, Poonawalla said that the vaccine trials in India will be completed by January, adding that the first dose has been given to most of the people who took part in the trial.

Sharing details of the final stage of trial for the Oxford-AstraZeneca’s Covid-19 vaccine in India, Poonawalla said, “We have already given the first dose to most of the patients in the trial, which is more than a 1,000 already. The total trial is for 1,600 patients in India. Then we will give the second dose and then and then analyse them for safety and efficacy.”

“That’s why I say January to be absolutely safe for India. Then again, we have to wait till all the data comes in from the UK to collate that together and then the Indian drug controller will have enough data to decide which way to go and when to license the product,” he added.

Adar Poonawalla also said that Oxford’s vaccine is producing a good immune response in addition to antibodies.

“The data is very good. If the UK goes into emergency licensure, it will be up to the government of India to then decide and take a call after analysing that data to determine whether we follow suit in about a month as well,” he said.

“Having said that, our own trial in India will be completed by January. So now it will be up to the UK health authorities and the Indian health authorities to take a decision on how safe and effective this vaccine is.”

Story Credit > www.ndtv.com 

Tags : #OxfordVaccine #AstraZenecaVaccine #SerumInstituteOfIndia #AdarPoonawala #LatestVaccineNewsOct30

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026